Literature DB >> 7585360

Characterization of diacetin B, a bacteriocin from Lactococcus lactis subsp. lactis bv. diacetylactis UL720.

D Ali1, C Lacroix, D Thuault, C M Bourgeois, R E Simard.   

Abstract

Fourteen Lactococcus lactis strains showing inhibitory activity against Listeria innocua SICC 4202 were isolated from different French raw milks and raw milk cheeses and screened for bacteriocin production by the triple layer method under conditions that eliminate the effects of lactic acid and hydrogen peroxide. Three bacteriocinogenic strains (two Lactococcus lactis subsp. lactis bv. diacetylactis UL719 and UL720 and one Lactococcus lactis subsp. lactis UL730) were selected for their high capacity to inhibit the growth of various food pathogens, including Listeria monocytogenes, Staphylococcus aureus, and clostridial strains. The inhibitory compounds from these three strains are inactivated by selected proteases, indicating their protein nature. They retained their antibacterial activity after heat treatments of 100 degrees C for 60 min and 121 degrees C for 20 min, and in the pH range from 2 to 11. The bacteriocin diacetin B produced by strain UL720 has been purified by a pH-dependent adsorption-desorption procedure, followed by reverse-phase high performance liquid chromatography, with a yield of 1.25% of the original activity. Mass spectrometry analysis indicates that the pure peptide has a molecular mass of 4292.32 or 4490.28 Da, while amino acid sequencing allowed the identification of the primary structure of the bacteriocin composed of 37 amino acid residues. The structure of the peptide did not show similarity with other known bacteriocins from lactic acid bacteria.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585360     DOI: 10.1139/m95-114

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  7 in total

1.  Ureaplasma urealyticum and Mycoplasma hominis sensitivity to bacteriocins produced by two Lactobacilli strains.

Authors:  M Daniele; F Ruiz; L Pascual; L Barberis
Journal:  Curr Microbiol       Date:  2011-07-30       Impact factor: 2.188

2.  Antimicrobial activity, inhibition of urogenital pathogens, and synergistic interactions between lactobacillus strains.

Authors:  Francisco O Ruiz; Gisela Gerbaldo; Paula Asurmendi; Liliana M Pascual; Walter Giordano; Isabel L Barberis
Journal:  Curr Microbiol       Date:  2009-11       Impact factor: 2.188

3.  Inhibition of Listeria innocua in cheddar cheese by addition of nisin Z in liposomes or by in situ production in mixed culture.

Authors:  R-O Benech; E E Kheadr; R Laridi; C Lacroix; I Fliss
Journal:  Appl Environ Microbiol       Date:  2002-08       Impact factor: 4.792

4.  Purification and partial characterization of novel bacteriocin L23 produced by Lactobacillus fermentum L23.

Authors:  Liliana M Pascual; María B Daniele; Walter Giordano; María C Pájaro; Isabel L Barberis
Journal:  Curr Microbiol       Date:  2008-01-03       Impact factor: 2.188

5.  Ex Vivo Differential Responsiveness to Clostridium perfringens and Lactococcus lactis by Avian Small Intestine Macrophages and T Cells.

Authors:  Nitish Boodhoo; Bahram Shojadoost; Mohammadali Alizadeh; Raveendra R Kulkarni; Shayan Sharif
Journal:  Front Immunol       Date:  2022-02-09       Impact factor: 7.561

6.  On Lactococcus lactis UL719 competitivity and nisin (Nisaplin(®)) capacity to inhibit Clostridium difficile in a model of human colon.

Authors:  Christophe Le Lay; Benoit Fernandez; Riadh Hammami; Marc Ouellette; Ismail Fliss
Journal:  Front Microbiol       Date:  2015-09-25       Impact factor: 5.640

7.  A Double-Blind Controlled Study to Evaluate the Effects of Yogurt Enriched with Lactococcus lactis 11/19-B1 and Bifidobacterium lactis on Serum Low-Density Lipoprotein Level and Antigen-Specific Interferon-γ Releasing Ability.

Authors:  Kyoko Nishiyama; Takahiro Kobayashi; Yuko Sato; Yoshihisa Watanabe; Riki Kikuchi; Ryoko Kanno; Tetsuo Koshizuka; Nozomu Miyazaki; Ken Ishioka; Tatsuo Suzutani
Journal:  Nutrients       Date:  2018-11-16       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.